NEO NeoGenomics, Inc. - Common Stock
关于 NeoGenomics, Inc. - Common Stock 公司概况(来自维基百科)
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
阅读更多
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
NEO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
NEO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
NEO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 4 25.0%
- 买入 7 43.8%
- 持有 5 31.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
9 位分析师 · 2026-08-14收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.05 | $0.03 | 0.02% |
| 2026年3月31日 | $0.01 | $0.01 | 0.00% |
| 2025年12月31日 | $0.06 | $0.04 | 0.02% |
| 2025年9月30日 | $0.03 | $0.02 | 0.01% |
| 2025年6月30日 | $0.03 | $0.02 | 0.01% |
| 2025年3月31日 | $0.00 | $-0.01 | 0.01% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
资产负债表 29
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
资产负债表 27
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $757M | $724M | · | $705M | $682M | $657M | · | $641M | $620M | $592M | · | $565M | $538M | $508M | · | $492M | |
| Net Income TTM | $-87M | $-115M | · | $-116M | $-107M | $-89M | · | $-82M | $-89M | $-101M | · | $-110M | $-127M | $-152M | · | $-142M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.5 | 1.3 | · | 1.4 | 1.4 | 1.9 | · | 2.9 | 2.9 | 3.4 | · | 2.8 | 3.8 | 4.4 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| P / FCF | · | -73.2 | · | · | · | -40.8 | · | · | · | -63.6 | · | · | · | -97.9 | · | · | |
| EV / EBITDA | -214.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $727M | $661M | $592M | $510M | $484M |
| 毛利率 % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| 营业利润率 % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| 净收入 | $-108M | $-79M | $-88M | $-144M | $-8M |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.4 | 0.6 | — | — | — |
| 流动比率 | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| 速动比率 | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-22M | $-34M | $-31M | $-97M | $-91M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 299 家申报者 · $1.8B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 64 (+22 与上一季度对比) | 38 (+1 与上一季度对比) | 93 (+20 与上一季度对比) | 59 (-26 与上一季度对比) | +33.5M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| First Light Asset Management, LLC | $179158241 | 12279523 | 9.76% | 股份 |
| VANGUARD GROUP INC | $150953759 | 12836204 | 8.22% | 股份 |
| FIRST TRUST ADVISORS LP | $147552477 | 10113261 | 8.04% | 股份 |
| Greenhouse Funds LLLP | $125097724 | 8574210 | 6.82% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117615272 | 8061362 | 6.41% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $84082418 | 5763017 | 4.58% | 股份 |
| STATE STREET CORP | $78257609 | 5363784 | 4.26% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73501000 | 5037787 | 4.00% | 股份 |
| BRAIDWELL LP | $71756567 | 4918202 | 3.91% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61886083 | 4342883 | 3.37% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50558727 | 3465300 | 2.75% | 买入期权 |
| MILLENNIUM MANAGEMENT LLC | $44930518 | 3079542 | 2.45% | 股份 |
| TORONTO DOMINION BANK | $43770000 | 3000000 | 2.38% | 买入期权 |
| GEODE CAPITAL MANAGEMENT, LLC | $42933596 | 2942009 | 2.34% | 股份 |
| Driehaus Capital Management LLC | $36604049 | 2508845 | 1.99% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34896129 | 2391784 | 1.90% | 股份 |
| AMERICAN CAPITAL MANAGEMENT INC | $32648145 | 2237707 | 1.78% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $32593724 | 2233977 | 1.78% | 股份 |
| UBS Group AG | $32581659 | 2233150 | 1.78% | 买入期权 |
| LOOMIS SAYLES & CO L P | $30838504 | 2113674 | 1.68% | 股份 |
| Aberdeen Group plc | $28180950 | 1931525 | 1.54% | 股份 |
| D. E. Shaw & Co., Inc. | $27938858 | 1914932 | 1.52% | 股份 |
| GLENMEDE TRUST CO NA | $20985657 | 1438359 | 1.14% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17689018 | 1212407 | 0.96% | 股份 |
| SEGALL BRYANT & HAMILL, LLC | $15850518 | 1086396 | 0.86% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $12685640 | 869475 | 0.69% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $11918848 | 816919 | 0.65% | 股份 |
| SAMLYN CAPITAL, LLC | $11869359 | 813527 | 0.65% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $11707337 | 802422 | 0.64% | 股份 |
| Glenmede Investment Management, LP | $11359995 | 1471502 | 0.62% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $9141555 | 626563 | 0.50% | 股份 |
| HighMark Wealth Management LLC | $8936871 | 612534 | 0.49% | 股份 |
| JUPITER ASSET MANAGEMENT LTD | $7841935 | 537487 | 0.43% | 股份 |
| Public Sector Pension Investment Board | $6526545 | 447330 | 0.36% | 股份 |
| Trexquant Investment LP | $6358074 | 435783 | 0.35% | 股份 |
| GOLDMAN SACHS GROUP INC | $5559884 | 381075 | 0.30% | 股份 |
| Bank of New York Mellon Corp | $5554938 | 380736 | 0.30% | 股份 |
| Granite Investment Partners, LLC | $5181507 | 355141 | 0.28% | 股份 |
| RHUMBLINE ADVISERS | $4624054 | 316935 | 0.25% | 股份 |
| AMERIPRISE FINANCIAL INC | $4623822 | 316917 | 0.25% | 股份 |
| Weiss Asset Management LP | $4171558 | 285919 | 0.23% | 股份 |
| Swiss National Bank | $3800695 | 260500 | 0.21% | 股份 |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3770056 | 258400 | 0.21% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $3680109 | 252235 | 0.20% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3455481 | 236839 | 0.19% | 股份 |
| FMR LLC | $3409026 | 233655 | 0.19% | 股份 |
| Squarepoint Ops LLC | $3239505 | 222036 | 0.18% | 股份 |
| ExodusPoint Capital Management, LP | $3128811 | 214449 | 0.17% | 股份 |
| Legal & General Group Plc | $2907700 | 199294 | 0.16% | 股份 |
| PEAK6 LLC | $2651003 | 181700 | 0.14% | 买入期权 |
| FEDERATED HERMES, INC. | $2510064 | 172040 | 0.14% | 股份 |
| BANK OF AMERICA CORP /DE/ | $2221357 | 152252 | 0.12% | 股份 |
| WHITE PINE CAPITAL LLC | $2167184 | 148539 | 0.12% | 股份 |
| PRUDENTIAL FINANCIAL INC | $2017870 | 138305 | 0.11% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $1987158 | 136200 | 0.11% | 股份 |
| BlackRock, Inc. | $1962691 | 134523 | 0.11% | 股份 |
| WELLS FARGO & COMPANY/MN | $1943067 | 133178 | 0.11% | 股份 |
| STEELHEAD PARTNERS LLC | $1885028 | 129200 | 0.10% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $1787859 | 122540 | 0.10% | 股份 |
| Greenhouse Funds LLLP | $1689522 | 115800 | 0.09% | 买入期权 |
| PERKINS CAPITAL MANAGEMENT INC | $1605483 | 110040 | 0.09% | 股份 |
| GABELLI FUNDS LLC | $1597605 | 109500 | 0.09% | 股份 |
| ARISTEIA CAPITAL, L.L.C. | $1571343 | 107700 | 0.09% | 股份 |
| IEQ CAPITAL, LLC | $1524305 | 104476 | 0.08% | 股份 |
| Verition Fund Management LLC | $1477019 | 101235 | 0.08% | 股份 |
| GAMCO INVESTORS, INC. ET AL | $1459000 | 100000 | 0.08% | 股份 |
| Fernwood Investment Management, LLC | $1453536 | 88200 | 0.08% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1440244 | 194103 | 0.08% | 股份 |
| XTX Topco Ltd | $1413552 | 96885 | 0.08% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1403354 | 96186 | 0.08% | 股份 |
| CITADEL ADVISORS LLC | $1324772 | 90800 | 0.07% | 买入期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1279178 | 87675 | 0.07% | 股份 |
| Curi Capital, LLC | $1256666 | 86132 | 0.07% | 股份 |
| MFG WEALTH MANAGEMENT, INC. | $1217711 | 83462 | 0.07% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $1189723 | 160340 | 0.06% | 股份 |
| MetLife Investment Management, LLC | $1120293 | 76785 | 0.06% | 股份 |
| Mariner, LLC | $1117405 | 76587 | 0.06% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1039421 | 71242 | 0.06% | 股份 |
| TWO SIGMA ADVISERS, LP | $983136 | 83600 | 0.05% | 股份 |
| Russell Investments Group, Ltd. | $967068 | 66283 | 0.05% | 股份 |
| VOYA INVESTMENT MANAGEMENT LLC | $962429 | 65965 | 0.05% | 股份 |
| MORGAN STANLEY | $954638 | 65431 | 0.05% | 股份 |
| Quantinno Capital Management LP | $945359 | 64795 | 0.05% | 股份 |
| Illinois Municipal Retirement Fund | $932520 | 63915 | 0.05% | 股份 |
| WINTON GROUP Ltd | $924700 | 63379 | 0.05% | 股份 |
| Quantbot Technologies LP | $922540 | 63231 | 0.05% | 股份 |
| CHOREO, LLC | $889115 | 60940 | 0.05% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $884373 | 60615 | 0.05% | 股份 |
| MOODY NATIONAL BANK TRUST DIVISION | $860445 | 58975 | 0.05% | 股份 |
| Louisiana State Employees Retirement System | $833089 | 57100 | 0.05% | 股份 |
| SIMPLEX TRADING, LLC | $796453 | 54589 | 0.04% | 股份 |
| JANE STREET GROUP, LLC | $786401 | 53900 | 0.04% | 买入期权 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $786109 | 53880 | 0.04% | 股份 |
| Teton Advisors, LLC | $774729 | 53100 | 0.04% | 股份 |
| Invesco Ltd. | $766515 | 52537 | 0.04% | 股份 |
| COMMERCE BANK | $764632 | 52408 | 0.04% | 股份 |
| Vanguard Global Advisers, LLC | $741070 | 50793 | 0.04% | 股份 |
| BARD ASSOCIATES INC | $683761 | 46865 | 0.04% | 股份 |
| Alamea Verwaltungs GmbH | $683702 | 46861 | 0.04% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $674467 | 46228 | 0.04% | 股份 |
公司内部人士 52 位内幕人士 · 30 位高管 · 23 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | 2025年6月1日 M | 20166 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | 2025年2月23日 M | 641585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | 2022年3月1日 A | 368051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | 2025年5月11日 M | 168332 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | 2022年4月28日 M | 191548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | 2019年3月1日 A | 10944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | 2024年2月23日 A | 148455 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | 2022年8月1日 A | 43216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | 2022年3月2日 F | 244157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | 2022年3月1日 A | 33443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | 2021年12月30日 A | 41280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | 2021年5月25日 M | 150101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | 2025年5月11日 M | 108280 | 0 | 0 | $0 |
| Alicia C Olivo | EVP, GC & Business Development | 2025年9月1日 F | 47940 | 0 | 0 | $0 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 2025年2月23日 M | 109755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | 2023年4月1日 F | 82673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | 2023年3月2日 F | 29765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | 2022年4月1日 A | 158684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | 2022年3月1日 A | 147396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 2022年1月11日 M | 49361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | 2021年12月30日 A | 48615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | 2021年4月22日 M | 130847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | 2021年3月2日 A | 60643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | 2018年10月22日 M | 45953 | 0 | 0 | $0 |
| Steven A Ross | CIO | 2018年5月10日 X | 4500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | 2017年5月25日 A | 60692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | 2016年1月28日 A | — | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | 2015年12月29日 X | 51218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | 2014年5月22日 X | 8439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | 2011年5月18日 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | 董事 | 2026年6月23日 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | 董事 | 2026年6月15日 S | 86115 | 0 | 2 | $-118824 |
| Marjorie C Green | 董事 | 2026年6月1日 A | 22964 | 0 | 0 | $0 |
| Neil Gunn | 董事 | 2026年6月1日 A | 51177 | 0 | 0 | $0 |
| Michael Aaron Kelly | 董事 | 2026年6月1日 A | 67086 | 0 | 0 | $0 |
| David Brian Perez | 董事 | 2026年6月1日 A | 56967 | 0 | 0 | $0 |
| John P. Kenny | 董事 | 2026年6月1日 A | 5893 | 0 | 0 | $0 |
| Stephen M Kanovsky | 董事 | 2026年6月1日 A | 75421 | 0 | 0 | $0 |
| Felicia Williams | 董事 | 2026年6月1日 A | 30237 | 0 | 0 | $0 |
| Elizabeth Floegel | 董事 | 2025年6月1日 A | 23590 | 0 | 0 | $0 |
| Alison L. Hannah | 董事 | 2025年6月1日 M | 131023 | 0 | 0 | $0 |
| Bruce K Crowther | 董事 | 2023年8月10日 A | 65120 | 0 | 0 | $0 |
| Rachel A Stahler | 董事 | 2022年6月10日 A | 21335 | 0 | 0 | $0 |
| David Daly | 董事 | 2022年6月10日 A | 17179 | 0 | 0 | $0 |
| Kevin C Johnson | 董事 | 2021年12月22日 M | 37398 | 0 | 0 | $0 |
| Douglas M Van Oort | 董事 | 2021年8月1日 F | 2468797 | 0 | 0 | $0 |
| Steven C Jones | 董事 | 2021年1月7日 M | 90218 | 0 | 0 | $0 |
| Raymond R Hipp | 董事 | 2020年11月16日 S | 66800 | 0 | 0 | $0 |
| William J Robison | 董事 | 2017年5月25日 A | 183348 | 0 | 0 | $0 |
| Michael T Dent | 董事 | 2014年12月4日 S | 1384150 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | 2007年4月12日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 62 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1.12% | 167212 SH | 2026年8月8日 | 每日 |
| PSCH · Invesco Exchange-Traded Fund Trus... | 1.09% | 113008 SH | 2026年8月8日 | 每日 |
| LFSC · RBB Fund, Inc. | 0.43% | 43071 NS | 2026年5月31日 | N-PORT |
| IHF · iShares Trust | 0.31% | 243554 SH | 2026年8月8日 | 每日 |
| FYC · First Trust Exchange-Traded Alpha... | 0.14% | 154408 NS | 2026年4月30日 | N-PORT |
| IJT · iShares Trust | 0.13% | 700692 SH | 2026年8月8日 | 每日 |
| XJR · iShares Trust | 0.13% | 15435 SH | 2026年8月8日 | 每日 |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.12% | 19262 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.12% | 211878 SH | 2026年8月8日 | 每日 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.12% | 89895 SH | 2026年8月8日 | 每日 |
| IWN · iShares Trust | 0.12% | 1117630 SH | 2026年8月8日 | 每日 |
| IJR · iShares Trust | 0.11% | 7947524 SH | 2026年8月8日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.11% | 104297 SH | 2026年8月8日 | 每日 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.10% | 455144 SH | 2026年8月8日 | 每日 |
| NUSC · Nushares ETF Trust | 0.10% | 135666 NS | 2026年4月30日 | N-PORT |
| IJS · iShares Trust | 0.09% | 489210 SH | 2026年8月8日 | 每日 |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.09% | 116046 SH | 2026年8月8日 | 每日 |
| ESML · iShares Trust | 0.09% | 158897 SH | 2026年8月8日 | 每日 |
| FYX · First Trust Exchange-Traded Alpha... | 0.07% | 93313 NS | 2026年4月30日 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.07% | 13856 NS | 2026年5月31日 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.07% | 85056 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.06% | 3340583 SH | 2026年8月8日 | 每日 |
| ISCG · iShares Trust | 0.06% | 40428 SH | 2026年8月8日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.06% | 49165 NS | 2026年4月30日 | N-PORT |
| SAA · ProShares Trust | 0.06% | 1546 NS | 2026年5月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 757699 SH | 2026年8月8日 | 每日 |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.05% | 33295 NS | 2026年4月30日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.05% | 1728845 SH | 2026年8月8日 | 每日 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.04% | 106278 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.04% | 55874 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.03% | 6071 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.03% | 5811 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.03% | 388986 SH | 2026年8月8日 | 每日 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.03% | 628556 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.03% | 425333 NS | 2026年4月30日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.03% | 14399 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 1492431 SH | 2026年8月8日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.02% | 2990594 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.02% | 4748 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 60531 NS | 2026年4月30日 | N-PORT |
| WSML · iShares Trust | 0.02% | 7690 SH | 2026年8月8日 | 每日 |
| SMLF · iShares Trust | 0.02% | 45201 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.01% | 4804 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 5288 NS | 2026年4月30日 | N-PORT |
| IWO · iShares Trust | 0.01% | 113167 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 12627 SH | 2026年8月8日 | 每日 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 5219 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 339840 NS | 2026年4月30日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 15340 NS | 2026年4月30日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 121 NS | 2026年5月31日 | N-PORT |